22 participants
Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-29
- Start Date:
- 2017-09-26
- Completion:
- 2020-05-19
Conditions
- Recurrent Chronic Lymphocytic Leukemia
- Recurrent Small Lymphocytic Lymphoma
- Refractory Chronic Lymphocytic Leukemia
- Refractory Small Lymphocytic Lymphoma
Interventions
- DRUG